Current Barriers to uACR Testing

Author(s):

Rajiv Agarwal, MD,Mark A. Meeker, DO, FACP, CPE

Key Takeaways

Limited awareness and lack of standardized protocols hinder uACR testing, necessitating enhanced provider education and patient awareness initiatives.
A multimodal approach, including lifestyle changes and pharmacotherapy, is crucial for achieving guideline goals in reducing uACR.
Early detection through increased CKD testing awareness can significantly improve patient outcomes by enabling timely interventions.
Engaging healthcare providers requires continuous education, routine practice integration, and leveraging technology for effective CKD management.

Panelists discuss the current barriers to urine albumin-creatinine ratio (uACR) testing, strategies to address these barriers, the guideline goals for reducing uACR, and the importance of a multimodal approach, as well as how increased awareness of chronic kidney disease (CKD) testing can improve patient outcomes and engage health care providers in promoting testing.

What are the current barriers to uACR testing?
1. How can these barriers to testing be addressed?
2. What are the guideline goals for reducing uACR? How much emphasis should be put on a multimodal approach to drive down uACR as much as possible?
How can increased awareness of CKD testing improve patient outcom
1. How can health care providers be engaged in promoting CKD testing?